According to a European study of 6,693 breast cancer patients, it is safe to trust genetic testing when it conflicts with results from traditional testing. In some cases, the genetic test may suggest that there is a low risk of the cancer spreading while other tests say the risk is high. The study indicated that in such scenarios, women were just as likely to survive for five years compared to those who had chemotherapy.

For many New York residents who are suffering from a rare disease, getting treatment can be very difficult. However, advocacy groups are working to get legislation passed that would help those suffering from a rare diseases to seek treatment.

There are some health-related issues that require a closer look in order to achieve a proper diagnosis. New York residents who are prone to various and seemingly unrelated illnesses that have no immediately recognizable cause may actually suffer from a commonly misdiagnosed disorder.

Ehlers-Danlos syndrome is a genetic condition that impacts how the body processes collagen. Collagen makes up about 30 percent of the human body, which means symptoms of the syndrome may be felt in multiple places. However, it is often difficult for patients in New York and elsewhere to be diagnosed with the condition because its symptoms may be seen as localized issues. For example, knee pain may be diagnosed as tendinitis while a shoulder issue may be seen as bursitis.

According to a new study in the August edition of the American Journal of Roentgenology, molecular breast imaging can locate cancers that mammograms miss. The research could improve breast cancer outcomes for women in New York and nationwide, particularly those who have dense breast tissue.